America Great Health (AAGH) SEC Filing 10-K Annual Report for the fiscal year ending Wednesday, June 30, 2021

America Great Health

CIK: 1098009 Ticker: AAGH
Document And Entity Information - USD ($)
12 Months Ended
Jun. 30, 2021
Jan. 20, 2021
Dec. 31, 2020
Document Information Line Items   
Entity Registrant NameAmerica Great Health  
Document Type10-K  
Current Fiscal Year End Date--06-30  
Entity Common Stock, Shares Outstanding 21,075,888,239 
Entity Public Float  $ 0
Amendment Flagfalse  
Entity Central Index Key0001098009  
Entity Current Reporting StatusNo  
Entity Voluntary FilersNo  
Entity Filer CategoryNon-accelerated Filer  
Entity Well-known Seasoned IssuerNo  
Document Period End DateJun. 30, 2021  
Document Fiscal Year Focus2021  
Document Fiscal Period FocusFY  
Entity Small Businesstrue  
Entity Emerging Growth Companytrue  
Entity Shell Companyfalse  
Entity Ex Transition Periodfalse  
ICFR Auditor Attestation Flagtrue  
Document Annual Reporttrue  
Document Transition Reportfalse  
Entity File Number000-27873  
Entity Incorporation, State or Country CodeWY  
Entity Tax Identification Number98-0178621  
Entity Address, Address Line One1609 W Valley Blvd Unit 338A  
Entity Address, City or TownAlhambra  
Entity Address, State or ProvinceCA  
Entity Address, Postal Zip Code91803  
City Area Code888  
Local Phone Number988-1333  
Title of 12(g) SecurityCommon Stock, no par value  
Entity Interactive Data CurrentNo  

View differences made from one year to another to evaluate America Great Health's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by America Great Health.


Assess how America Great Health's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

America Great Health's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statement Of Shareholders' Equity
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Accounting Policies, By Policy (Policies)
Convertible, Redeemable Preferred Stock
Convertible, Redeemable Preferred Stock (Details)
Equity Investment
Equity Investment (Details)
Equity Investment (Details) - Equity Method Investments
Equity Investment (Details) - Equity Method Investments (Parentheticals)
Equity Investment (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Details) - Schedule Of Deferred Tax Assets And Liabilities
Income Taxes (Details) - Schedule Of Effective Income Tax Rate Reconciliation
Income Taxes (Tables)
Lease (Details)
Lease (Details) - Lease, Cost
Lease (Details) - Lessee, Operating Lease, Liability, Maturity
Lease (Tables)
Long Term Loan
Long Term Loan (Details)
Long Term Loan (Details) - Schedule Of Long-Term Debt Instruments
Long Term Loan (Details) - Schedule Of Long-Term Debt Instruments (Parentheticals)
Long Term Loan (Tables)
Nature Of Business
Nature Of Business (Details)
Other Receivable
Other Receivable (Details)
Other Receivable (Details) - Schedule Of Accounts, Notes, Loans And Financing Receivable
Other Receivable (Tables)
Related Party Transactions
Related Party Transactions (Details)
Shareholders' Deficit
Shareholders' Deficit (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)

Material Contracts, Statements, Certifications & more

America Great Health provided additional information to their SEC Filing as exhibits

Ticker: AAGH
CIK: 1098009
Form Type: 10-K Annual Report
Accession Number: 0001185185-22-000080
Submitted to the SEC: Thu Jan 20 2022 8:38:40 PM EST
Accepted by the SEC: Fri Jan 21 2022
Period: Wednesday, June 30, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: